Pediatrix Medical Group, Inc.

MD Healthcare Medical Care Facilities

Pediatrix Medical Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.9 billion, down 4.92% from fiscal 2024.

Revenue
+1.72%
EPS
−27.6%
Free cash flow
−14.4%
Total debt
−4.11%

Quarter to September 2026, against a year earlier

31.73 1.07 −3.26%
Market cap
$2.5B
P/E
17.1×
Fwd P/E
15.3×
Dividend yield
—
F-score
7/9
Altman Z
2.05
Beneish M
−2.86
Dividend safety
n/a

Pediatrix Medical Group, Inc. (MD) EV/EBITDA

Alert me on EV/EBITDA

As of 5 November 2026, Pediatrix Medical Group, Inc. (MD) trades at a EV/EBITDA of 11.0×. Over the past ten years it has ranged from 0.0× (June 2025) to 44.1× (April 2024); the current reading is higher than 42% of that period. That is below the Medical Care Facilities industry median of 11.9× and above the Healthcare sector median of 8.4×.

EV/EBITDA, daily

Embed this chart

Annual newest first

Period EV/EBITDA Change
FY2025 8.2× —
FY2024 0.0× —
FY2023 27.4× 219.73%
FY2022 8.6× (27.34%)
FY2021 11.8× (39.38%)
FY2020 19.5× 29.37%
FY2019 15.1× (15.06%)
FY2018 17.7× 39.65%
FY2017 12.7× 7.91%
FY2016 11.8× (6.99%)

Quarterly newest first

Period EV/EBITDA Change
Sep 2026 9.0× (1.42%)
Jun 2026 9.2× 11.28%
Mar 2026 8.2× 0.61%
Dec 2025 8.2× 17.47%
43 more quarters

Against its own ten years

Low 0.0× High 44.1×
Ten-year median 11.8×
Current reading's percentile 42

EV/EBITDA against peers

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on MD